Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

(13)C glucose labelling studies using 2D NMR are a useful tool for determining ex vivo whole organ metabolism during hypothermic machine perfusion of kidneys.

Nath J, Smith T, Hollis A, Ebbs S, Canbilen SW, Tennant DA, Ready AR, Ludwig C.

Transplant Res. 2016 Aug 5;5:7. doi: 10.1186/s13737-016-0037-0. eCollection 2016.

2.

Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.

Rausch L, Koenecke C, Koch HF, Kaltenborn A, Emmanouilidis N, Pape L, Lehner F, Arelin V, Baumann U, Schrem H.

Transplant Res. 2016 Aug 2;5:6. doi: 10.1186/s13737-016-0036-1. eCollection 2016.

3.

From motivation to acceptability: a survey of public attitudes towards organ donation in Denmark.

Nordfalk F, Olejaz M, Jensen AM, Skovgaard LL, Hoeyer K.

Transplant Res. 2016 May 23;5:5. doi: 10.1186/s13737-016-0035-2. eCollection 2016.

4.

Protocol for a prospective randomized controlled trial of recipient remote ischaemic preconditioning in orthotopic liver transplantation (RIPCOLT trial).

Robertson FP, Goswami R, Wright GP, Fuller B, Davidson BR.

Transplant Res. 2016 Apr 6;5:4. doi: 10.1186/s13737-016-0033-4. eCollection 2016.

5.

Some considerations on the current debate about typing resolution in solid organ transplantation.

Vogiatzi P.

Transplant Res. 2016 Mar 8;5:3. doi: 10.1186/s13737-016-0032-5. eCollection 2016.

6.

The role of CYP3A5 polymorphism and dose adjustments following conversion of twice-daily to once-daily tacrolimus in renal transplant recipients.

Zaltzman AS, Glick LA, Zaltzman JS, Nash M, Huang M, Prasad GV.

Transplant Res. 2016 Jan 28;5:2. doi: 10.1186/s13737-016-0031-6. eCollection 2016.

7.

Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence.

Castellaneta A, Massaro A, Rendina M, D'Errico F, Carparelli S, Rizzi SF, Thomson AW, Di Leo A.

Transplant Res. 2016 Jan 20;5:1. doi: 10.1186/s13737-016-0030-7. eCollection 2016.

8.

Contraindications to kidney transplantation: uneven grounds?

Kiberd BA, AlBugami MM, Panek R, Tennankore K.

Transplant Res. 2015 Jul 21;4:2. doi: 10.1186/s13737-015-0024-x. eCollection 2015.

9.

A moral dilemma argument against clinical trials of incentives for kidney donation.

Prasad GV.

Transplant Res. 2015 Jul 22;4:3. doi: 10.1186/s13737-015-0025-9. eCollection 2015.

10.

Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?

Geissler EK.

Transplant Res. 2015 Jan 14;4:1. doi: 10.1186/s13737-014-0022-4. eCollection 2015. Review.

11.

Multipotent adult progenitor cells decrease cold ischemic injury in ex vivo perfused human lungs: an initial pilot and feasibility study.

La Francesca S, Ting AE, Sakamoto J, Rhudy J, Bonenfant NR, Borg ZD, Cruz FF, Goodwin M, Lehman NA, Taggart JM, Deans R, Weiss DJ.

Transplant Res. 2014 Nov 1;3(1):19. doi: 10.1186/2047-1440-3-19. eCollection 2014.

12.
13.

Reviewing 15 years of experience with sirolimus.

Tedesco Silva H Jr, Rosso Felipe C, Medina Pestana JO.

Transplant Res. 2015 Dec 22;4(Suppl 1):6. doi: 10.1186/s13737-015-0028-6. eCollection 2015. Review.

14.

Practical considerations for the use of mTOR inhibitors.

Diekmann F, Campistol JM.

Transplant Res. 2015 Dec 22;4(Suppl 1):5. doi: 10.1186/s13737-015-0029-5. eCollection 2015. Review.

15.

Proceedings of the 13th international transplantation symposia: mTOR-inhibition: what have we learned and how so we best apply the learning.

Jardine AG.

Transplant Res. 2015 Dec 22;4(Suppl 1):4. doi: 10.1186/s13737-015-0027-7. eCollection 2015. No abstract available.

16.

Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study.

Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E, Johnston N, Jardine AG, Mark PB.

Transplant Res. 2014 Dec 3;3(1):20. doi: 10.1186/s13737-014-0020-6. eCollection 2014.

17.

Factors influencing survival after kidney transplant failure.

McCaughan JA, Patterson CC, Maxwell AP, Courtney AE.

Transplant Res. 2014 Sep 24;3:18. doi: 10.1186/2047-1440-3-18. eCollection 2014.

18.

Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT).

Tiwari AK, Pandey P, Aggarwal G, Dara RC, Rawat G, Raina V, Soin AS.

Transplant Res. 2014 Sep 12;3:17. doi: 10.1186/2047-1440-3-17. eCollection 2014.

19.

The feasibility and applications of non-invasive cardiac output monitoring, thromboelastography and transit-time flow measurement in living-related renal transplantation surgery: results of a prospective pilot observational study.

Goodyear SJ, Barnes J, Imray CE, Higgins R, Lam FT, Kashi SH, Tan LC, Imray CH.

Transplant Res. 2014 Aug 29;3:16. doi: 10.1186/2047-1440-3-16. eCollection 2014.

20.

Active video gaming in patients with renal transplant: a pilot study.

Wang DW, Sills LL, MacDonald SB, Maianski Z, Alwayn I.

Transplant Res. 2014 Aug 9;3:15. doi: 10.1186/2047-1440-3-15. eCollection 2014.

Supplemental Content

Loading ...
Support Center